| Head‐to‐head comparison of the pharmacokinetic profiles of a high‐purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients wit... AP T Lissitchkov, M Matysiak, K Zavilska, P Laguna, L Gercheva, A Antonov, A ... Haemophilia 5 (19), 674-678, 2013 | 40* | 2013 |
| A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high‐purity factor IX concentrate, in patients with severe haemophilia B T Lissitchkov, M Matysiak, K Zavilska, P Łaguna, L Gercheva, A Antonov, ... Haemophilia 17 (4), 590-596, 2011 | 29 | 2011 |
| Pharmacokinetic study of a high‐purity factor IX concentrate (Factor IX Grifols®) with a 6‐month follow up in previously treated patients with severe haemophilia B TL JA Aznar, N Cabrera, M Matysiak, K Zawilska, L Gercheva, A Antonov, M ... Haemophilia 15 (6), 1243-1248, 2009 | 21 | 2009 |
| An open clinical study assessing the efficacy and safety of Factor IX Grifols®, a high‐purity Factor IX concentrate, in patients with severe haemophilia B AP T Lissitchkov, M Matysiak, K Zawilska, L Gercheva, A Antonov, M Montañes Haemophilia 16 (2), 240-246, 2010 | 15 | 2010 |
| Clinical case of acute myeloblastic leukemia with t (8; 21)(q22; q22) in a patient with Klinefelter’s syndrome V Slavcheva, T Lukanov, G Balatsenko, S Angelova, A Antonov, ... Hematology Reports 2 (1), e11, 2010 | 2 | 2010 |
| Evaluation of the correlation between JAK2V617F, leucocytosis and thrombogenic risk in patients with Polycythemia Vera and Essential thrombocythemia A Antonov, L Gercheva, N Stefanova, M Tzaneva, T Chervenkov Journal of IMAB–Annual Proceeding Scientific Papers 24 (3), 2085-2090, 2018 | | 2018 |
| BORTEZOMIB MAINTENANCE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA-A SINGLE CENTER EXPERIENCE LG 5. I Micheva, S Dimitrova, R Rachev, H Varbanov, M Mehmed, V Gerov, A Antonov HAEMATOLOGICA. :, 796-796, 2016 | | 2016 |
| A case-report of severe tropical malaria complicated with acute renal failure and hemolytic anaemia D Radkova, K Stoyanova, T Tsvetkova, A Antonov, S Pavlov Varna Medical Forum 4 (1), 22-28, 2015 | | 2015 |
| KËÈÍÈ×ÅÍ ÑËÓ×ÀÉ ÍÀ ÒÅÆÊÀ ÒÐÎÏÈ×ÅÑÊÀ ÌÀËÀÐÈß, ÓÑËÎÆÍÅÍÀ Ñ ÎÑÒÐÀ ÁÚÁÐÅ×ÍÀ ÍÅÄÎÑÒÀÒÚ×ÍÎÑÒ È ÕÅÌÎËÈÒÈ×ÍÀ ÀÍÅÌÈß ÑÏ Äèàíà Ðàäêîâà1, Êàëèíà Ñòîÿíîâà1, Òàòÿíà Öâåòêîâà1, Àíòîíèî Àíòîíîâ2 Âàðíåíñêè ìåäèöèíñêè ôîðóì 4 (1), 22, 2015 | | 2015 |
| Head-to-head comparative study of the pharmacokinetic behavior of a high-purity factor ix concentrate (alphanine®) and a recombinant factor ix (benefix®) in patient... TL JA Aznar, A Moret, N Cabrera, M Matysiak, K Zavilska, L Gercheva, A ... Journal of Thrombosis and Haemostasis 11, 99, 2013 | | 2013 |
| ÑËÓ×ÀÉ ÍÀ ÅÊÑÒÐÀÌÅÄÓËÀÐÅÍ ÏËÀÇÌÎÖÈÒÎÌ ÍÀ ÖÍÑ ÏÐÈ ÆÅÍÀ ÍÀ 29 Ã., ÏÐÎÃÐÅÑÈÐÀË ÄÎ ÌÍÎÆÅÑÒÂÅÍ ÌÈÅËÎÌ Ñ ÔÀÒÀËÅÍ ÈÇÕÎÄ Ì Åôðàèì, À Àíòîíîâ, È Ìè÷åâà, Âë Ãåðîâ, Ë Ãåð÷åâà Êëèíè÷íà è Òðàíñôóçèîííà Õåìàòîëîãèÿ 159 (¹ 1-2), 73, 2013 | | 2013 |
| Ñëó÷àé íà åêñòðàìåäóëàðåí ïëàçìîöèòîì íà ÖÍÑ ïðè æåíà íà 29 ã., ïðîãðåñèðàë äî ìíîæåñòâåí ìèåëîì ñ ôàòàëåí èçõîä, Êëèíè÷íà è òðàíñôóçèîííà õåìàòîëîãèÿ 2013, 1-2:73-77 ÂÃËà Ì. Åôðàèì, À.Àíòîíîâ, È.Ìè÷åâà Êëèíè÷íà è òðàíñôóçèîííà õåìàòîëîãèÿ 1 (7), 2013 | | 2013 |
| A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high‐purity factor IX concentrate, in patients with severe haemophilia B AP T Lissitchkov, M Matysiak, K Zavilska, P Łaguna, L Gercheva, A Antonov, N ... Haemophilia 17 (4), 590-596, 2011 | | 2011 |
| A clinical study assessing the pharmacokinetics, efficacy and safety of AlphaNine®, a high-purity factor IX concentrate, in patients with severe haemophilia B A ANTONOV, N CABRERA, JA AZNAR, MK WOODWARD Haemophilia 1, 7, 2010 | | 2010 |
| Factor V Leiden and C677T MTHFR thrombophilic mutations associated with hyperfibrinogenemia, persistent high CRP and leucocytosis in newborn baby with perinatal infection--a … K Vulkova, A, Kovacheva, A Antonov Akusherstvo i ginekologiia 48 (4), 51-54, 2009 | | 2009 |
| Genetic thrombophilic defects and risk of thrombotic complications in patients with essential thrombocythemia and polycythemia vera. Part I. prevalence of genetic thrombophilic … K Kovacheva, A Antonov Clinical and Transfusion Haematology 43 (1), 2007 | | 2007 |
| Genetic thrombophilic defects and risk of thrombotic complications in patients with essential thrombocythemia and polycythemia vera Part II. Contribution of the genetic … K Antonov, Antonio: Kovacheva Clinical and Transfusion Haematology 43 (1), 2007 | | 2007 |
| Inherited thrombophilia - Genetic defects and screening K Kovacheva, A Antonov Clinical and Transfusion Haematology 43 (1), 57-62, 2007 | | 2007 |
| Prognostic value of CD38 in patients with B-chronic lymphocytic leukemia V Slavcheva, A Antonov, A Velkova Clinical and Transfusion Haematology, 2005 | | 2005 |
| Elevated plasma levels of vascular endothelial growth factor and hepatocyte growth factor in patients with chronic myeloproliferative disorders A Zheliazkova, L Gercheva, L Ivanova, A Antonov Clinical and Transfusion Haematology, 2003 | | 2003 |
Liana Gercheva - KyuchukovaAcibadem City Clinic Tokuda HospitalVerified email at acibademcityclinic.bg
